Kathleen Moore, MD

Gynecologic Oncologist

Accepting New Patients
Member of OU Health Physicians

4.8 out of 5

(76 Ratings) , 74 Comments

Position: Gynecologic Oncologist
Primary Specialty: Gynecologic Oncology
Additional Specialty: Phase I Cancer Clinical Trials
Languages Spoken: English
Gender: Female

About Kathleen Moore

Kathleen Moore, M.D., is a gynecologic oncologist with OU Health Stephenson Cancer Center in Oklahoma City. She is also the director of the Oklahoma TSET Phase I Program, the state's only phase I clinical trials program and a national leader in accruals.

She earned her medical degree at University of Washington School of Medicine in Seattle, WA. She completed her residency in gynecology at the University Health Center of Pittsburgh in Pittsburgh, PA and completed a fellowship in gynecologic oncology at the University of Oklahoma College of Medicine in Oklahoma City, OK.

Awards

The Best Medical Student Teaching Resident, University of Pittsburgh 2002
Senior Resident Research Award, Magee-Women’s Hospital 2004
Golden Pillar Award for Patient Satisfaction 2011

Health Education

Medical School
Doctor of Medicine University of Washington School of Medicine
Seattle, WA

Fellowship
Gyneclogic Oncology University of Oklahoma College of Medicine
Oklahoma City, OK

Residency
Obstetrics & Gynecology University Health Center of Pittsburgh
Pittsburgh, PA

Reviews

10/04/2024

Again depends
03/18/2024

Dr. Moore has that winning combination of professionalism and knowledge combined with an ease and effective manner in which she communicates. I appreciate her thoroughness and the way she collaborates with my doctor in Alaska. It is a joy working with Dr. Moore.
12/06/2023

Dr Moore is always attentive and knowledgeable. I appreciate the ability to see her.
11/23/2023

Dr. Kathleen Moore is an exceptionally competent physician and researcher. We are extremely fortunate to be able to discuss our family's case with her and look forward to doing so in the future. We are all lucky to have her working on problems in ovarian cancer.